Evidence map›Paper›PMID 27139508›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2016

Discovery, Total Synthesis and Key Structural Elements for the Immunosuppressive Activity of Cocosolide, a Symmetrical Glycosylated Macrolide Dimer from Marine Cyanobacteria.

Sarath P Gunasekera, Yang Li, Ranjala Ratnayake, Danmeng Luo, Jeannette Lo, Joseph H Reibenspies, Zhengshuang Xu, Michael J Clare-Salzler, Tao Ye, Valerie J Paul and 1 more

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Total Synthesis of Endolides A and B.Synlett : accounts and rapid communications in synthetic organic chemistry · 2019
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Sarath P GunasekeraSmithsonian Marine Station, 701 Seaway Drive, Fort Pierce, Florida, 34949, USA.
Yang LiLaboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School of Peking University, Shenzhen, 518055, P.R. China.
Ranjala RatnayakeDepartment of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville, Florida, 32610, USA.
Danmeng LuoDepartment of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville, Florida, 32610, USA.
Jeannette LoDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, 32610, USA.
Joseph H ReibenspiesDepartment of Chemistry, Texas A & M University, College Station, Texas, 77843, USA.
Zhengshuang XuLaboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School of Peking University, Shenzhen, 518055, P.R. China.
Michael J Clare-SalzlerDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, 32610, USA.
Tao YeLaboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School of Peking University, Shenzhen, 518055, P.R. China. yet@pkusz.edu.cn.
Valerie J PaulSmithsonian Marine Station, 701 Seaway Drive, Fort Pierce, Florida, 34949, USA. paul@si.edu.
Hendrik LueschDepartment of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville, Florida, 32610, USA. luesch@cop.ufl.edu.
University of Florida · USBGI Group (China) · CNSmithsonian Marine Station · USPeking University · CNTexas A&M University · US

Funding

Novel Targeted Anticancer Agents from Marine CyanobacteriaR01CA172310 · NCI · UNIVERSITY OF FLORIDA · PI HENDRIK LUESCH · 2013 to 2026
$5.8M
NCI NIH HHS R01 CA172310
6 · The paper itself

Abstract

A new dimeric macrolide xylopyranoside, cocosolide (1), was isolated from the marine cyanobacterium preliminarily identified as Symploca sp. from Guam. The structure was determined by a combination of NMR spectroscopy, HRMS, X-ray diffraction studies and Mosher's analysis of the base hydrolysis product. Its carbon skeleton closely resembles that of clavosolides A-D isolated from the sponge Myriastra clavosa, for which no bioactivity is known. We performed the first total synthesis of cocosolide (1) along with its [α,α]-anomer (26) and macrocyclic core (28), thus leading to the confirmation of the structure of natural 1. The convergent synthesis featured Wadsworth-Emmons cyclopropanation, Sakurai annulation, Yamaguchi macrocyclization/dimerization reaction, α-selective glycosidation and β-selective glycosidation. Compounds 1 and 26 potently inhibited IL-2 production in both T-cell receptor dependent and independent manners. Full activity requires the presence of the sugar moiety as well as the intact dimeric structure. Cocosolide also suppressed the proliferation of anti-CD3-stimulated T-cells in a dose-dependent manner.

Indexed as

AnimalsAnti-Bacterial AgentsBacillus cereusCell ProliferationCell SurvivalCrystallography, X-RayCyanobacteriaDimerizationDrug Evaluation, PreclinicalGlycosidesGlycosylationHCT116 CellsHumansImmunosuppressive AgentsInterleukin-2Jurkat CellsAnti-Bacterial AgentscocosolideGlycosidesImmunosuppressive AgentsInterleukin-2LipopolysaccharidesMacrolidesNitric Oxideglycosidesmacrolidesmarine natural productsstructure elucidationtotal synthesis

Identifiers

PMID27139508
PMCPMC5224530
OpenAlexW2345603810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.